أعرض في EDS

Oral azacitidine preserves favorable level of fatigue and health-related quality of life for patients with acute myeloid leukemia in remission: results from the phase 3, placebo-controlled QUAZAR AML-001 trial

التفاصيل البيبلوغرافية
العنوان:	Oral azacitidine preserves favorable level of fatigue and health-related quality of life for patients with acute myeloid leukemia in remission: results from the phase 3, placebo-controlled QUAZAR AML-001 trial
المؤلفون:	Uwe M. Martens, Jun Ho Jang, Farhad Ravandi, Julia Braverman, Shien Guo, Ming Chung Wang, Jane L. Liesveld, C.L. Beach, Teresa Bernal, Barry S. Skikne, Christopher Pocock, Jiří Mayer, Peiwen Yu, Hartmut Döhner, Gail J. Roboz, Qian Dong, Ling Shi, Dominik Selleslag, Andrew H. Wei, Salem Abi Nehme, Ignazia La Torre, Hervé Dombret
المصدر:	Haematologica. 106:3240-3244
بيانات النشر:	Ferrata Storti Foundation (Haematologica), 2021.
سنة النشر:	2021
مصطلحات موضوعية:	Oncology, Health related quality of life, medicine.medical_specialty, business.industry, Internal medicine, medicine, MEDLINE, Myeloid leukemia, Hematology, Placebo, business, Oral Azacitidine
تدمد:	1592-8721 0390-6078
الوصول الحر:	https://explore.openaire.eu/search/publication?articleId=doi_________::cc56742deef2ae04ca2a891cfa3f2060Test https://doi.org/10.3324/haematol.2021.279174Test
حقوق:	OPEN
رقم الانضمام:	edsair.doi...........cc56742deef2ae04ca2a891cfa3f2060
قاعدة البيانات:	OpenAIRE

الوصف
تدمد:	15928721 03906078